Helicobacter pylori eradication reduced the risk for ulcers in dyspeptic patients who were about to begin NSAID treatment
- ERADICATE THE BUG BEFORE YOU START THE DRUG? Metz, David C.; Johnson, David // American Journal of Gastroenterology;Feb1998, Vol. 93 Issue 2, p279
Presents a commentary about a randomized trial of eradication of Helicobacter pylori before nonsteroidal anti-inflammatory drug (NSAID) therapy to prevent peptic ulcers. Evaluation and treatment of patients with nonulcer dyspepsia; Controversy regarding strategies for primary prevention of...
- Treatment of Peptic Ulcer Disease and Nonulcer Dyspepsia. Meurer, Linda N. // Journal of Family Practice;Jul2001, Vol. 50 Issue 7, p614
The article explains the treatment of peptic ulcer disease and nonulcer dyspepsia (NUD). It notes that the pathophysiology of nonulcer dyspepsia is not definitively known though factors implicated include gastric acid secretion, gastro-duodenal dysmotility, visceral hypersensitivity, stress and...
- Low-risk criteria for dyspepsia under age 45. // Journal of Family Practice;Jul2006, Vol. 55 Issue 7, p568
The article discusses the endoscopic evaluation of dyspepsia in patients between the ages of 18 and 45 years. The patients in this study had an average age of 35 years and were then divided into three groups based on their risk factors and symptoms. Group A were nonsteroidal anti-inflammatory...
- Has the Impact of Helicobacter pylori Therapy on Ulcer Recurrence in the United States Been Overstated? Laine, Loren; Hopkins, Robert J.; Girardi, Luigi S. // American Journal of Gastroenterology;Sep1998, Vol. 93 Issue 9, p1409
Objective: The aim of this study was to assess the effect of H. pylori eradication on ulcer recurrence in North American duodenal ulcer patients by examining only treatment studies that met rigorous methodologic criteria. Methods: Data sources were computerized bibliographic searches...
- Use of NSAIDs and infection with Helicobacter pylori–what does the rheumatologist need to know? Kiltz, U.; Zochling, J.; Schmidt, W. E.; Braun, J. // Rheumatology;Sep2008, Vol. 47 Issue 9, p1342
Objectives. NSAID-induced gastroduodenal lesions are a frequent and potentially serious health problem in patients with rheumatic diseases. Helicobacter pylori (H. pylori) has also been recognized as a major risk factor for the development of ulcer disease. However, the role of H. pylori in the...
- Serologic testing is more cost-effective strategy for ulcer symptoms. // Geriatrics;Oct95, Vol. 50 Issue 10, p16
Reports that antibiotic therapy following a positive serology for Helicobacter pylori appears to be the most cost-effective approach in treating patients with symptoms of peptic ulcers. Non-application of the strategy to treating peptic ulcer symptoms caused by chronic use of non-steroidal...
- DEBUGging Your Ulcer RISK. M.A.D. // Arthritis Today;Mar/Apr2003, Vol. 17 Issue 2, p36
Discusses the link between the Helicobacter pylori bacterium and the risk of stomach ulcers associated with nonsteroidal anti-inflammatory drugs (NSAID). Factors that increase the risk of NSAID-induced ulcers.
- Helicobacter pylori infection common in ulcer patients. // Cortlandt Forum;02/25/99, Vol. 12 Issue 2, p15
Informs that chronic Helicobacter pylori infection has been increasingly associated with gastric and duodenal ulcers unrelated to nonsteroidal anti-inflammatory drugs (NSAID). Role of H. pylori infection in the pathogenesis of nonulcer dyspepsia, particularly in users of NSAID.
- Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Approaching the end of the controversy in the new millennium, or room for more debate? Leong, Rupert W. L.; Chan, Francis K. L.; Sung, Joseph J. Y. // Journal of Gastroenterology;2001, Vol. 36 Issue 11, p731
Examines the risk factors posed by Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAID) in the pathogenesis of gastrointestinal tract ulcers. Damages of the mucosa from Helicobacter pylori and NSAID; Effect of NSAID on Helicobacter pylori eradication.